Rare diseases
Investigational molecules
Locations
800 Commissioners Rd E, N6A 5W9
Clinical research is centered on Long Covid, with attention to persistent symptom burden and recovery challenges following acute infection. The funded work focuses on therapeutic options intended to improve symptom severity and address ongoing functional impairment.
The research portfolio reflects interest in repurposed drug approaches for managing chronic manifestations of COVID-19, with a therapeutic emphasis on relieving lingering multisystem symptoms.
Dr. Douglas D. Fraser runs clinical trials in conditions such as Post-acute COVID-19 syndrome, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
